Struthers Richard Scott Insider Trades

Insider Trading History

Track insider trading activity for Struthers Richard Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $13.7M 413,563 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$821k 21,981 shares
$37.37
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $14.1M 426,759 shares
Last Trade
Feb 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7M 290,000 shares
$43.79
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $8.57M 259,058 shares
Last Trade
Dec 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.02M 44,742 shares
$45.14
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $12.1M 364,759 shares
Last Trade
Dec 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.02M 44,742 shares
$45.14
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $3.51M 106,000 shares
Last Trade
Sep 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$180k 4,000 shares
$45.00
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $10.6M 320,017 shares
Last Trade
May 14, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.83M 90,400 shares
$31.29
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $21.9M 661,205 shares
Last Trade
May 14, 2025 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.83M 90,400 shares
$31.29
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.55M 81,270 shares
$31.39
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $13.6M 410,417 shares
Last Trade
Apr 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.55M 81,270 shares
$31.39
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $10.9M 330,022 shares
Last Trade
Mar 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$593k 17,338 shares
$34.20
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $11.5M 346,485 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5M 313,000 shares
$36.86
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $3.31M 100,000 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$576k 10,000 shares
$57.57
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $12.1M 364,933 shares
Last Trade
May 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.47M 107,448 shares
$50.89
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $541k 16,342 shares
Last Trade
May 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.47M 107,448 shares
$50.89
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $8.52M 257,485 shares
Last Trade
May 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.31M 107,448 shares
$49.40
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $8.52M 257,485 shares
Last Trade
Apr 18, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$15.1k 350 shares
$43.01
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $2.69M 81,270 shares
Last Trade
Apr 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$874k 20,000 shares
$43.68
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $8.53M 257,835 shares
Last Trade
Apr 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$874k 20,000 shares
$43.68
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $7.87M 237,835 shares
Last Trade
Apr 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.01M 40,951 shares
$49.17
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
President & CEO
Holding Value $9.23M 278,786 shares
Last Trade
Apr 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.91M 40,951 shares
$46.65
$33.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up